<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yu J</submitter><funding>National Institute of Arthritis and Musculoskeletal and Skin Diseases</funding><funding>NEI NIH HHS</funding><funding>Dermatology Foundation</funding><funding>National Institutes of Health</funding><funding>NIAMS NIH HHS</funding><pagination>3950-9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2996908</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(10)</volume><pubmed_abstract>microRNA-205 (miR-205) and miR-184 coordinately regulate the lipid phosphatase SHIP2 for Akt survival signaling in keratinocytes. As the PI3K-Akt pathway has also been implicated in regulating the actin cytoskeleton and cell motility, we investigated the role that these 2 miRNAs play in keratinocyte migration. We used antagomirs (antago) to reduce the levels of miR-205 and miR-184 in primary human epidermal keratinocytes (HEKs) and corneal epithelial keratinocytes (HCEKs) as well as direct SHIP2 silencing using siRNA oligos. Treatment of HEKs and HCEKs with antago-205 increased SHIP2 levels and impaired the ability of these cells to seal linear scratch wounds compared with untreated or irrelevant-antago treatments. In contrast, AKT signaling was enhanced and wounds sealed faster in HCEKs where miR-184 was suppressed, enabling miR-205 to inhibit SHIP2. Similar increases in migration were observed following direct SHIP2 silencing in HEKs. Furthermore, down-regulation of miR-205 resulted in an increase in Rho-ROCKI activity, phosphorylation of the actin severing protein cofilin, and a corresponding diminution of filamentous actin. The connection among miR-205, RhoA-ROCKI-cofilin inactivation, and the actin cytoskeleton represents a novel post-translational mechanism for the regulation of normal human keratinocyte migration.</pubmed_abstract><journal>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</journal><pubmed_title>MicroRNA-205 promotes keratinocyte migration via the lipid phosphatase SHIP2.</pubmed_title><pmcid>PMC2996908</pmcid><funding_grant_id>P30AR057216</funding_grant_id><funding_grant_id>EY017536</funding_grant_id><funding_grant_id>P30 AR057216</funding_grant_id><funding_grant_id>R21 EY017536</funding_grant_id><funding_grant_id>EY019463</funding_grant_id><funding_grant_id>R01 EY019463</funding_grant_id><pubmed_authors>Peng H</pubmed_authors><pubmed_authors>Lavker RM</pubmed_authors><pubmed_authors>Ruan Q</pubmed_authors><pubmed_authors>Yu J</pubmed_authors><pubmed_authors>Fatima A</pubmed_authors><pubmed_authors>Getsios S</pubmed_authors></additional><is_claimable>false</is_claimable><name>MicroRNA-205 promotes keratinocyte migration via the lipid phosphatase SHIP2.</name><description>microRNA-205 (miR-205) and miR-184 coordinately regulate the lipid phosphatase SHIP2 for Akt survival signaling in keratinocytes. As the PI3K-Akt pathway has also been implicated in regulating the actin cytoskeleton and cell motility, we investigated the role that these 2 miRNAs play in keratinocyte migration. We used antagomirs (antago) to reduce the levels of miR-205 and miR-184 in primary human epidermal keratinocytes (HEKs) and corneal epithelial keratinocytes (HCEKs) as well as direct SHIP2 silencing using siRNA oligos. Treatment of HEKs and HCEKs with antago-205 increased SHIP2 levels and impaired the ability of these cells to seal linear scratch wounds compared with untreated or irrelevant-antago treatments. In contrast, AKT signaling was enhanced and wounds sealed faster in HCEKs where miR-184 was suppressed, enabling miR-205 to inhibit SHIP2. Similar increases in migration were observed following direct SHIP2 silencing in HEKs. Furthermore, down-regulation of miR-205 resulted in an increase in Rho-ROCKI activity, phosphorylation of the actin severing protein cofilin, and a corresponding diminution of filamentous actin. The connection among miR-205, RhoA-ROCKI-cofilin inactivation, and the actin cytoskeleton represents a novel post-translational mechanism for the regulation of normal human keratinocyte migration.</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Oct</publication><modification>2025-04-05T15:53:11.508Z</modification><creation>2019-03-27T00:01:28Z</creation></dates><accession>S-EPMC2996908</accession><cross_references><pubmed>20530248</pubmed><doi>10.1096/fj.10-157404</doi></cross_references></HashMap>